Clinical Trial Update: Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant chemotherapy with or without targeted therapy in T3-4N2 colorectal cancer patients is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Colorectal Cancer, Chemotherapy Effect | Phase 3 | Status: RECRUITING